83 related articles for article (PubMed ID: 8260336)
1. Occult malignancy is associated with venous thrombosis unresponsive to adequate anticoagulation.
Adamson DJ; Currie JM
Br J Clin Pract; 1993; 47(4):190-1. PubMed ID: 8260336
[TBL] [Abstract][Full Text] [Related]
2. Disseminated coagulopathies and advanced malignancies.
Fengler SA; Berenberg JL; Lee YT
Am Surg; 1990 Jun; 56(6):335-8. PubMed ID: 2350105
[TBL] [Abstract][Full Text] [Related]
3. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP
Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097
[TBL] [Abstract][Full Text] [Related]
4. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
[TBL] [Abstract][Full Text] [Related]
5. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
6. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
Sallah S; Wan JY; Nguyen NP
Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
8. [Deep venous thrombosis and neoplastic pathology: our experience in emergencies].
Schillaci F; Stagnitti F; Iurato C; Mongardini M; Dall'olio D; Salvi PF; Cazzaniga M; Bresadola L; Schultze W; Natalini E
G Chir; 1998; 19(6-7):293-300. PubMed ID: 9707837
[TBL] [Abstract][Full Text] [Related]
9. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
Palosuo T; Virtamo J; Haukka J; Taylor PR; Aho K; Puurunen M; Vaarala O
Thromb Haemost; 1997 Oct; 78(4):1178-82. PubMed ID: 9364981
[TBL] [Abstract][Full Text] [Related]
10. [Venous thrombosis of the legs and cancer. Evaluation of risk factors of venous thrombosis in the medical environment].
Giauffret F; Pottier P; Pistorius MA; Planchon B
J Mal Vasc; 1997 Oct; 22(4):234-8. PubMed ID: 9411008
[TBL] [Abstract][Full Text] [Related]
11. [Blood coagulation changes and neoplastic pathology].
Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
[TBL] [Abstract][Full Text] [Related]
12. Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice.
Donati MB
Thromb Haemost; 1995 Jul; 74(1):278-81. PubMed ID: 8578472
[TBL] [Abstract][Full Text] [Related]
13. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome.
Mason DP; Quader MA; Blackstone EH; Rajeswaran J; DeCamp MM; Murthy SC; Quader AK; Rice TW
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):711-8. PubMed ID: 16515928
[TBL] [Abstract][Full Text] [Related]
14. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
15. [Occult cancer and venous thromboembolism: which screening in patients with inaugural deep vein thrombosis?].
Lévesque H
Pathol Biol (Paris); 2008 Jun; 56(4):205-10. PubMed ID: 18343603
[TBL] [Abstract][Full Text] [Related]
16. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states.
Feied CF
Semin Dermatol; 1993 Jun; 12(2):135-49. PubMed ID: 8512794
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism in travellers: can we identify those at risk?
McQuillan AD; Eikelboom JW; Baker RI
Blood Coagul Fibrinolysis; 2003 Oct; 14(7):671-5. PubMed ID: 14517493
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
19. Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma.
Sletnes KE; Holte H; Halvorsen S; Jakobsen E; Wisløff F; Kvaløy S
Bone Marrow Transplant; 1996 Apr; 17(4):577-81. PubMed ID: 8722358
[TBL] [Abstract][Full Text] [Related]
20. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.
Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR
Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
